Sanofi (SNY) Non-Current Debt (2016 - 2025)
Sanofi's Non-Current Debt history spans 17 years, with the latest figure at $16.6 billion for Q4 2025.
- On a quarterly basis, Non-Current Debt rose 31.63% to $16.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $16.6 billion, a 31.63% increase, with the full-year FY2025 number at $16.6 billion, up 31.63% from a year prior.
- Non-Current Debt hit $16.6 billion in Q4 2025 for Sanofi, up from $14.9 billion in the prior quarter.
- Over the last five years, Non-Current Debt for SNY hit a ceiling of $21.6 billion in Q2 2021 and a floor of $12.6 billion in Q4 2024.
- Historically, Non-Current Debt has averaged $16.2 billion across 5 years, with a median of $15.5 billion in 2023.
- Biggest five-year swings in Non-Current Debt: dropped 22.62% in 2022 and later soared 31.63% in 2025.
- Tracing SNY's Non-Current Debt over 5 years: stood at $19.6 billion in 2021, then dropped by 22.62% to $15.2 billion in 2022, then increased by 1.84% to $15.4 billion in 2023, then decreased by 18.38% to $12.6 billion in 2024, then soared by 31.63% to $16.6 billion in 2025.
- Business Quant data shows Non-Current Debt for SNY at $16.6 billion in Q4 2025, $14.9 billion in Q2 2025, and $12.6 billion in Q4 2024.